{"id":"https://openalex.org/W2016553294","doi":"https://doi.org/10.1111/j.1365-2141.2008.07210.x","title":"R\u2010CHOP followed by consolidative autologous stem cell transplant and low dose rituxan maintenance therapy for advanced mantle cell lymphoma","display_name":"R\u2010CHOP followed by consolidative autologous stem cell transplant and low dose rituxan maintenance therapy for advanced mantle cell lymphoma","publication_year":2008,"publication_date":"2008-05-28","ids":{"openalex":"https://openalex.org/W2016553294","doi":"https://doi.org/10.1111/j.1365-2141.2008.07210.x","mag":"2016553294","pmid":"https://pubmed.ncbi.nlm.nih.gov/18510683"},"language":"en","primary_location":{"id":"doi:10.1111/j.1365-2141.2008.07210.x","doi":"https://doi.org/10.1111/j.1365-2141.2008.07210.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1365-2141.2008.07210.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2141.2008.07210.x","source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},"volume":null,"type":"letter","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2141.2008.07210.x","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5046533826","display_name":"Seah H. Lim","orcid":"https://orcid.org/0000-0002-4135-5989","observed_orcids":["https://orcid.org/0000-0002-4135-5989"]},"institutions":[{"id":"https://openalex.org/I2800124591","display_name":"Texas Oncology","ror":"https://ror.org/02ketev28","country_code":"US","type":"facility","lineage":["https://openalex.org/I2800124591"]},{"id":"https://openalex.org/I4210126781","display_name":"Harrington Regional Medical Center","ror":"https://ror.org/039whrd55","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126781"]},{"id":"https://openalex.org/I4210130556","display_name":"Harrington Cancer Center","ror":"https://ror.org/03ak9f780","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210130556"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Seah H. Lim","raw_affiliation_strings":["Biotherapy and Stem Cell Transplant Program, Texas Oncology Cancer Center; Oncology Unit, Northwest Texas Hospital Healthcare System, and Harrington Regional Medical Center, Inc., Amarillo, TX, USA.E-mail: seah.lim@usoncology.com","Biotherapy and Stem Cell Transplant Program, Texas Oncology Cancer Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biotherapy and Stem Cell Transplant Program, Texas Oncology Cancer Center; Oncology Unit, Northwest Texas Hospital Healthcare System, and Harrington Regional Medical Center, Inc., Amarillo, TX, USA.E-mail: seah.lim@usoncology.com","institution_ids":["https://openalex.org/I4210126781","https://openalex.org/I4210130556"]},{"raw_affiliation_string":"Biotherapy and Stem Cell Transplant Program, Texas Oncology Cancer Center","institution_ids":["https://openalex.org/I2800124591"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108504807","display_name":"William V. Esler","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800124591","display_name":"Texas Oncology","ror":"https://ror.org/02ketev28","country_code":"US","type":"facility","lineage":["https://openalex.org/I2800124591"]},{"id":"https://openalex.org/I4210126781","display_name":"Harrington Regional Medical Center","ror":"https://ror.org/039whrd55","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126781"]},{"id":"https://openalex.org/I4210130556","display_name":"Harrington Cancer Center","ror":"https://ror.org/03ak9f780","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210130556"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"William V. Esler","raw_affiliation_strings":["Biotherapy and Stem Cell Transplant Program, Texas Oncology Cancer Center; Oncology Unit, Northwest Texas Hospital Healthcare System, and Harrington Regional Medical Center, Inc., Amarillo, TX, USA.E-mail: seah.lim@usoncology.com","Biotherapy and Stem Cell Transplant Program, Texas Oncology Cancer Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biotherapy and Stem Cell Transplant Program, Texas Oncology Cancer Center; Oncology Unit, Northwest Texas Hospital Healthcare System, and Harrington Regional Medical Center, Inc., Amarillo, TX, USA.E-mail: seah.lim@usoncology.com","institution_ids":["https://openalex.org/I4210126781","https://openalex.org/I4210130556"]},{"raw_affiliation_string":"Biotherapy and Stem Cell Transplant Program, Texas Oncology Cancer Center","institution_ids":["https://openalex.org/I2800124591"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111539832","display_name":"Phillip Periman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800124591","display_name":"Texas Oncology","ror":"https://ror.org/02ketev28","country_code":"US","type":"facility","lineage":["https://openalex.org/I2800124591"]},{"id":"https://openalex.org/I4210126781","display_name":"Harrington Regional Medical Center","ror":"https://ror.org/039whrd55","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126781"]},{"id":"https://openalex.org/I4210130556","display_name":"Harrington Cancer Center","ror":"https://ror.org/03ak9f780","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210130556"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Phillip O. Periman","raw_affiliation_strings":["Biotherapy and Stem Cell Transplant Program, Texas Oncology Cancer Center; Oncology Unit, Northwest Texas Hospital Healthcare System, and Harrington Regional Medical Center, Inc., Amarillo, TX, USA.E-mail: seah.lim@usoncology.com","Biotherapy and Stem Cell Transplant Program, Texas Oncology Cancer Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biotherapy and Stem Cell Transplant Program, Texas Oncology Cancer Center; Oncology Unit, Northwest Texas Hospital Healthcare System, and Harrington Regional Medical Center, Inc., Amarillo, TX, USA.E-mail: seah.lim@usoncology.com","institution_ids":["https://openalex.org/I4210126781","https://openalex.org/I4210130556"]},{"raw_affiliation_string":"Biotherapy and Stem Cell Transplant Program, Texas Oncology Cancer Center","institution_ids":["https://openalex.org/I2800124591"]}]},{"author_position":"middle","author":{"id":null,"display_name":"David Beggs","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800124591","display_name":"Texas Oncology","ror":"https://ror.org/02ketev28","country_code":"US","type":"facility","lineage":["https://openalex.org/I2800124591"]},{"id":"https://openalex.org/I4210126781","display_name":"Harrington Regional Medical Center","ror":"https://ror.org/039whrd55","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126781"]},{"id":"https://openalex.org/I4210130556","display_name":"Harrington Cancer Center","ror":"https://ror.org/03ak9f780","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210130556"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"David Beggs","raw_affiliation_strings":["Biotherapy and Stem Cell Transplant Program, Texas Oncology Cancer Center; Oncology Unit, Northwest Texas Hospital Healthcare System, and Harrington Regional Medical Center, Inc., Amarillo, TX, USA.E-mail: seah.lim@usoncology.com","Biotherapy and Stem Cell Transplant Program, Texas Oncology Cancer Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biotherapy and Stem Cell Transplant Program, Texas Oncology Cancer Center; Oncology Unit, Northwest Texas Hospital Healthcare System, and Harrington Regional Medical Center, Inc., Amarillo, TX, USA.E-mail: seah.lim@usoncology.com","institution_ids":["https://openalex.org/I4210126781","https://openalex.org/I4210130556"]},{"raw_affiliation_string":"Biotherapy and Stem Cell Transplant Program, Texas Oncology Cancer Center","institution_ids":["https://openalex.org/I2800124591"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080964500","display_name":"Yana Zhang","orcid":"https://orcid.org/0000-0003-4463-1827","observed_orcids":["https://orcid.org/0000-0003-4463-1827"]},"institutions":[{"id":"https://openalex.org/I2800124591","display_name":"Texas Oncology","ror":"https://ror.org/02ketev28","country_code":"US","type":"facility","lineage":["https://openalex.org/I2800124591"]},{"id":"https://openalex.org/I4210126781","display_name":"Harrington Regional Medical Center","ror":"https://ror.org/039whrd55","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126781"]},{"id":"https://openalex.org/I4210130556","display_name":"Harrington Cancer Center","ror":"https://ror.org/03ak9f780","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210130556"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Yana Zhang","raw_affiliation_strings":["Biotherapy and Stem Cell Transplant Program, Texas Oncology Cancer Center; Oncology Unit, Northwest Texas Hospital Healthcare System, and Harrington Regional Medical Center, Inc., Amarillo, TX, USA.E-mail: seah.lim@usoncology.com","Biotherapy and Stem Cell Transplant Program, Texas Oncology Cancer Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biotherapy and Stem Cell Transplant Program, Texas Oncology Cancer Center; Oncology Unit, Northwest Texas Hospital Healthcare System, and Harrington Regional Medical Center, Inc., Amarillo, TX, USA.E-mail: seah.lim@usoncology.com","institution_ids":["https://openalex.org/I4210126781","https://openalex.org/I4210130556"]},{"raw_affiliation_string":"Biotherapy and Stem Cell Transplant Program, Texas Oncology Cancer Center","institution_ids":["https://openalex.org/I2800124591"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5068795567","display_name":"Mary K. Townsend","orcid":"https://orcid.org/0000-0003-2452-4477","observed_orcids":["https://orcid.org/0000-0003-2452-4477","https://orcid.org/0000-0002-9954-4846"]},"institutions":[{"id":"https://openalex.org/I2800124591","display_name":"Texas Oncology","ror":"https://ror.org/02ketev28","country_code":"US","type":"facility","lineage":["https://openalex.org/I2800124591"]},{"id":"https://openalex.org/I4210126781","display_name":"Harrington Regional Medical Center","ror":"https://ror.org/039whrd55","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126781"]},{"id":"https://openalex.org/I4210130556","display_name":"Harrington Cancer Center","ror":"https://ror.org/03ak9f780","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210130556"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Mary Townsend","raw_affiliation_strings":["Biotherapy and Stem Cell Transplant Program, Texas Oncology Cancer Center; Oncology Unit, Northwest Texas Hospital Healthcare System, and Harrington Regional Medical Center, Inc., Amarillo, TX, USA.E-mail: seah.lim@usoncology.com","Biotherapy and Stem Cell Transplant Program, Texas Oncology Cancer Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biotherapy and Stem Cell Transplant Program, Texas Oncology Cancer Center; Oncology Unit, Northwest Texas Hospital Healthcare System, and Harrington Regional Medical Center, Inc., Amarillo, TX, USA.E-mail: seah.lim@usoncology.com","institution_ids":["https://openalex.org/I4210126781","https://openalex.org/I4210130556"]},{"raw_affiliation_string":"Biotherapy and Stem Cell Transplant Program, Texas Oncology Cancer Center","institution_ids":["https://openalex.org/I2800124591"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5046533826","https://openalex.org/A5068795567","https://openalex.org/A5080964500","https://openalex.org/A5108504807","https://openalex.org/A5111539832"],"corresponding_institution_ids":["https://openalex.org/I2800124591","https://openalex.org/I4210126781","https://openalex.org/I4210130556"],"apc_list":{"value":5190,"currency":"USD","value_usd":5190},"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":5,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"142","issue":"3","first_page":"482","last_page":"484"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12212","display_name":"CNS Lymphoma Diagnosis and Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/r-chop","display_name":"R-CHOP","score":0.8009999990463257},{"id":"https://openalex.org/keywords/autologous-stem-cell-transplantation","display_name":"autologous stem cell transplantation","score":0.9629999995231628},{"id":"https://openalex.org/keywords/consolidation-therapy","display_name":"consolidation therapy","score":0.7170000076293945},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.42899999022483826}],"concepts":[{"id":"https://openalex.org/C2779429289","wikidata":"https://www.wikidata.org/wiki/Q408977","display_name":"Vincristine","level":4,"score":0.7779839038848877},{"id":"https://openalex.org/C2777525834","wikidata":"https://www.wikidata.org/wiki/Q268713","display_name":"Mantle cell lymphoma","level":3,"score":0.7626204490661621},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6810004115104675},{"id":"https://openalex.org/C2778684742","wikidata":"https://www.wikidata.org/wiki/Q2298283","display_name":"Melphalan","level":3,"score":0.5598278045654297},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.5455994606018066},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.5344390869140625},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5313755869865417},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5060109496116638},{"id":"https://openalex.org/C2776611710","wikidata":"https://www.wikidata.org/wiki/Q16888295","display_name":"Induction chemotherapy","level":3,"score":0.5033571124076843},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.48732075095176697},{"id":"https://openalex.org/C2779050716","wikidata":"https://www.wikidata.org/wiki/Q4826373","display_name":"Autologous stem-cell transplantation","level":3,"score":0.48177215456962585},{"id":"https://openalex.org/C2778283404","wikidata":"https://www.wikidata.org/wiki/Q6736822","display_name":"Maintenance therapy","level":3,"score":0.4367806315422058},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.42803284525871277},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.37761062383651733},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3729953169822693},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.2737457752227783}],"mesh":[{"descriptor_ui":"D000069283","descriptor_name":"Rituximab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D003131","descriptor_name":"Combined Modality Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011239","descriptor_name":"Prednisolone","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014750","descriptor_name":"Vincristine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D020522","descriptor_name":"Lymphoma, Mantle-Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D020522","descriptor_name":"Lymphoma, Mantle-Cell","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D033581","descriptor_name":"Stem Cell Transplantation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D058846","descriptor_name":"Antibodies, Monoclonal, Murine-Derived","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1365-2141.2008.07210.x","doi":"https://doi.org/10.1111/j.1365-2141.2008.07210.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1365-2141.2008.07210.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2141.2008.07210.x","source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},{"id":"pmid:18510683","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18510683","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of haematology","raw_type":"Comment"}],"best_oa_location":{"id":"doi:10.1111/j.1365-2141.2008.07210.x","doi":"https://doi.org/10.1111/j.1365-2141.2008.07210.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1365-2141.2008.07210.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2141.2008.07210.x","source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2016553294.pdf","grobid_xml":"https://content.openalex.org/works/W2016553294.grobid-xml"},"referenced_works_count":6,"referenced_works":["https://openalex.org/W41845000","https://openalex.org/W1492275783","https://openalex.org/W2058056801","https://openalex.org/W2065984192","https://openalex.org/W2079925501","https://openalex.org/W2087949958"],"related_works":["https://openalex.org/W2276844073","https://openalex.org/W2810686959","https://openalex.org/W7167266596","https://openalex.org/W3113369778","https://openalex.org/W2082121080","https://openalex.org/W7214401595","https://openalex.org/W4296531542","https://openalex.org/W2914452493","https://openalex.org/W2597875946","https://openalex.org/W2788050080"],"abstract_inverted_index":{"We":[0,214],"have":[1,155,185,215,698],"read":[2],"with":[3,58,123,224,309,338,568,574,649,656],"great":[4],"interest":[5],"the":[6,14,85,107,111,116,129,153,172,179,196,206,261,275,283,291,354,382,396,414,457,462,506,510,555,584,589,604,632,706],"report":[7,173],"by":[8,25,79,145,174,232,413,474,710],"Evens":[9,175,711],"et":[10,159,162,166,176,617,637,712],"al":[11,177,713],"(2008)":[12],"on":[13],"result":[15],"of":[16,21,49,52,110,115,119,182,198,323,342,369,385,399,416,419,423,436,461,509,520,571,578,641,673,681,694,715],"a":[17,233,301,339,417,434,441,475,575,657,692,699],"phase":[18],"II":[19],"study":[20],"intensive":[22,44],"chemotherapy":[23,143],"followed":[24,78,144,231,409],"consolidative":[26,74,138,234,718],"autologous":[27,80,139,146,235,280,287,388,425,487,494,719],"stem":[28,375,426],"cell":[29,36],"transplant":[30,207],"(SCT)":[31],"for":[32,134,171,205,588,691,721],"newly":[33,219,310],"diagnosed":[34,220,311],"mantle":[35],"lymphoma":[37],"(MCL)":[38],"patients.":[39,625,682,723,736],"In":[40],"this":[41,83,124],"study,":[42],"an":[43,716],"induction":[45,125,372],"chemotherapeutic":[46,200],"regimen":[47,126,244],"consisted":[48],"alternating":[50],"cycles":[51,368],"cyclophosphamide,":[53],"teniposide,":[54],"doxorubicin":[55],"and":[56,63,90,96,208,335,353,387,473,533,553,564,586,593,654,664,677,704,729],"prednisone":[57],"vincristine,":[59,228],"high":[60,75,240,605],"dose":[61,76,142,241,298,402,435,606],"methotrexate":[62],"cytarabine":[64],"was":[65,94,137,407,431,453,466,480,496,591,620,661],"used.":[66],"Thirteen":[67],"patients":[68,121,184,258,292,308,325,363,485,513,644,695],"\u226465":[69],"years":[70,264,278,344],"then":[71],"proceeded":[72],"to":[73,195,210,217,491,505,526,536,733],"busulfan/cyclophosphamide":[77],"SCT.":[81,140,281,488],"With":[82],"approach,":[84],"5-year":[86],"event-free":[87,674],"survival":[88,92,136,675,679],"(EFS)":[89,676],"overall":[91,678],"(OS)":[93,680],"54%":[95],"75%,":[97],"respectively.":[98],"These":[99],"results":[100,154,191,684],"are":[101,192,326],"encouraging,":[102],"especially":[103],"taking":[104],"into":[105],"account":[106],"long":[108],"follow-up":[109,181,577],"study.":[112],"Further":[113],"analysis":[114],"whole":[117],"group":[118,590,693],"25":[120],"treated":[122],"showed":[127],"that":[128,609,660],"one":[130,535,547,655],"single":[131,238,442],"factor":[132],"predicting":[133],"improved":[135],"High":[141,401],"SCT":[147,236,288,389,495,720],"has":[148,245],"been":[149,156,187,247],"investigated":[150],"previously,":[151],"but":[152],"conflicting":[157,190],"(Andersen":[158],"al,":[160,163,167,618,638],"1997;Khouri":[161],"2003;":[164],"Dreger":[165],"2000).":[168],"Furthermore,":[169,252],"except":[170,608],"(2008),":[178,714],"median":[180,340,459,576],"these":[183,324,642,722],"generally":[186],"short.":[188],"The":[189,320,626,683],"probably":[193],"related":[194],"use":[197],"different":[199,211],"agents":[201],"as":[202,256,371,440,601,613,708],"conditioning":[203],"regimens":[204],"also":[209,271],"post-transplant":[212],"therapy.":[213],"chosen":[216],"induce":[218],"advanced":[221,312],"stage":[222],"MCL":[223,317],"R-CHOP":[225,370,386],"(cyclophosphamide,":[226],"doxorubicin,":[227],"prednisolone,":[229],"rituximab),":[230],"after":[237,265,279],"agent":[239],"melphalan.":[242],"This":[243,451,559,724],"not":[246],"previously":[248,615],"tested":[249],"in":[250,328,482,545,622],"MCL.":[251],"we":[253],"reasoned":[254],"that,":[255],"most":[257],"relapse":[259,543],"within":[260,392],"first":[262,276],"two":[263,277,512],"transplant,":[266],"maintenance":[267,429,557,634],"rituximab":[268,299,556,633],"therapy":[269,430],"might":[270],"be":[272,731],"useful":[273],"during":[274,554],"Because":[282],"tumor":[284],"load":[285],"following":[286,493],"is":[289,561,565,726],"low,":[290],"may":[293],"only":[294,546],"need":[295],"intermittent":[296],"low":[297],"over":[300],"2":[302,367,420],"year-period.":[303],"Following":[304],"consent,":[305],"eight":[306,362,484,624],"consecutive":[307],"Stage":[313,351,358],"III":[314,352],"or":[315],"IV":[316,359],"were":[318,332,377,600],"treated.":[319],"clinical":[321,702],"characteristics":[322],"shown":[327],"Table":[329],"I.":[330],"There":[331],"five":[333],"males":[334],"three":[336,446,665],"females,":[337],"age":[341,460,508],"61":[343],"(range":[345,499,581],"47\u201372":[346],"years).":[347],"One":[348,522],"patient":[349,523,560],"had":[350,357,645],"other":[355],"seven":[356],"disease.":[360],"All":[361],"received":[364],"remission":[365,469],"+":[366],"chemotherapy.":[373],"Autologous":[374],"cells":[376],"harvested":[378],"upon":[379],"recovery":[380],"from":[381,395,515,551,603],"last":[383,397],"cycle":[384,398],"carried":[390],"out":[391],"6":[393],"weeks":[394],"R-CHOP.":[400],"intravenous":[403,668],"melphalan":[404],"(200":[405],"mg/m2)":[406],"administered,":[408],"24":[410],"h":[411],"later":[412],"infusion":[415,443],"minimum":[418],"\u00d7":[421],"106/kg":[422],"CD34+":[424],"cells.":[427],"Rituximab":[428],"initiated":[432],"at":[433,530,539],"375":[437],"mg/m2,":[438],"given":[439],"once":[444],"every":[445],"months":[447,532,550,580],"starting":[448],"Day":[449],"+100.":[450],"approach":[452,725],"well":[454,727],"tolerated.":[455],"Despite":[456],"higher":[458],"patients,":[463],"treatment-related":[464],"mortality":[465],"0%.":[467],"Complete":[468],"(CR),":[470],"documented":[471],"clinically":[472],"positron":[476],"emission":[477],"tomography":[478],"scan,":[479],"achieved":[481],"all":[483,623],"before":[486],"Median":[489],"time":[490],"engraftment":[492],"13":[497],"d":[498],"9\u201330":[500],"d).":[501],"Not":[502],"surprisingly,":[503],"due":[504,525],"older":[507,735],"group,":[511],"died":[514,524],"non-lymphoma":[516],"causes,":[517],"without":[518],"evidence":[519],"lymphoma.":[521],"metastatic":[527],"breast":[528],"cancer":[529],"34":[531],"another":[534],"myocardial":[537],"infarction":[538],"40":[540],"months.":[541],"Lymphoma":[542],"occurred":[544],"patient,":[548],"28":[549],"diagnosis":[552],"period.":[558],"still":[562],"alive":[563],"being":[566],"re-induced":[567],"velcade/dexamethasone.":[569],"As":[570],"February":[572],"2008,":[573],"54":[579],"28\u201376":[582],"months),":[583],"EFS":[585],"OS":[587],"57%":[592],"67%,":[594],"respectively":[595],"(Fig":[596],"1).":[597],"Adverse":[598],"effects":[599],"expected":[602],"melphalan,":[607],"delayed":[610,627],"immunoglobulin":[611,628,669],"reconstitution,":[612],"reported":[614],"(Lim":[616,636],"2005),":[619],"observed":[621],"reconstitution":[629],"persisted":[630],"beyond":[631],"period":[635],"2008).":[639],"Four":[640],"hypogammaglobulinemic":[643],"recurrent":[646,650],"infections":[647],"(three":[648],"respiratory":[651],"tract":[652],"infection":[653],"chronic":[658],"diarrhoea":[659],"Vancomycin":[662],"sensitive)":[663],"required":[666],"monthly":[667],"replacement.":[670],"Kaplan\u2013Meier":[671],"estimate":[672],"presented":[685],"here":[686],"are,":[687],"therefore,":[688],"extremely":[689],"encouraging":[690],"who":[696],"normally":[697],"very":[700],"poor":[701],"outcome,":[703],"support":[705],"notion,":[707],"suggested":[709],"early":[717],"tolerated":[728],"could":[730],"applied":[732],"even":[734]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}